People | 22 February 2022
Biosion appoints Joel Edwards as Chief Business Officer
Prior to joining Biosion, Edwards was Vice President of Corporate Strategy and operations at Ionis Pharmaceuticals.
Prior to joining Biosion, Edwards was Vice President of Corporate Strategy and operations at Ionis Pharmaceuticals.
He will be responsible for developing the company's pipeline of partnered and in-house discovery programs,
John served as General Manager for Catalent Pharma Solutions in St. Petersburg, Florida
Victor Dillard as VP Corporate Development and Lorna Peers as VP Finance
In the interim, Deepak Khanna will lead Human Health International.
Dr. Raman has succeeded Victoria Richon
Virginia will be responsible for meeting client needs for both media and commercial analytics.
Waksal holds a successful track record of founding, scaling and advising growth-oriented companies.
Brian joins LEO Pharma from Novo Nordisk, U.S. where he served as Senior Vice President of Sales.
She holds a Masters degree in Genetics along with a Ph.D. in Biochemistry
Senior R&D leader from Pfizer and bluebird bio to support Strand’s platform of programmable mRNA-based therapeutics
Rahul has spent almost 17 years at Boston Consulting Group (BCG) where he has led the Health Care & Life Sciences practice
Takes charge to lead business innovation, strategy, alliance & partnerships
New role strengthens Quantori’s global leadership position in data science & digital IT
The appointment is key for DefiniGEN as they expand the service portfolio to encompass compound screening
Ram’s appointment follows the launch of the CDI India division in October 2021.
He holds nine US patents and has published in multiple peer-reviewed journals and conferences
Prior to IHH, Anurag held senior leadership roles in Fortis Healthcare and Manipal Health Enterprises.
Dr Woler joins Sygnature Discovery after the company received significant investment from Five Arrows Principal Investments, the European corporate private equity arm of Rothschild & Co, in 2021
Narayanan to lead SeQuent through next phase of consolidation and growth
Subscribe To Our Newsletter & Stay Updated
